Francis Finucane (@francisfinucane) 's Twitter Profile
Francis Finucane

@francisfinucane

Endocrinologist. Bariatric Physician. Programme Director for Ireland’s first MSc in Obesity at University of Galway.

ID: 497854695

linkhttps://www.universityofgalway.ie/courses/taught-postgraduate-courses/obesity-msc.html calendar_today20-02-2012 12:41:08

7,7K Tweet

2,2K Followers

1,1K Following

Francis Finucane (@francisfinucane) 's Twitter Profile Photo

Thanks for a great piece on sleep and obesity catherine conlon. I get the compelling observational associations between poor sleep and weight gain. Do you know have any studies shown that improving sleep leads to significant weight loss in people with obesity and sleep disorders?

Andrew Coogan (@cooganlab) 's Twitter Profile Photo

Francis Finucane catherine conlon Current state-of-the-art for CBT-insomnia intervention for cardiometabolic health (not specifically in obesity): tandfonline.com/doi/full/10.10…

Fiona Gaughran 💙 (@fgaughran) 's Twitter Profile Photo

Francis Finucane catherine conlon Very interesting article catherine conlon - Francis Finucane Cherie Galletly’s group has done some work including weight outcomes post CPAP in people living with schizophrenia and obstructive sleep apnoea pubmed.ncbi.nlm.nih.gov/30450286/

Dr Davenport (@drcdav) 's Twitter Profile Photo

catherine conlon Current Biology HSE Health & Wellbeing RCSI School of Population Health UCC School of Public Health Institute of Public Health Irish College of GPs Irish Heart Foundation Francis Finucane I definitely agree that sleep is very important in this context. I’m just not sure the scientific evidence is entirely there that telling/helping people to target sleep will actually produce significant and long-term weight-related health benefits in obesity. (1/2)

Dr Davenport (@drcdav) 's Twitter Profile Photo

catherine conlon Current Biology HSE Health & Wellbeing RCSI School of Population Health UCC School of Public Health Institute of Public Health Irish College of GPs Irish Heart Foundation Francis Finucane I do think it’s important to target this intervention as part of an MDT approach (low risk, possible benefit) but would suggest that be presented as complementary with agents like the drugs, not a proven or superior alternative. Still very much appreciate the article. (2/2)

msteele.bsky.social (@mags_steele) 's Twitter Profile Photo

catherine conlon Current Biology HSE Health & Wellbeing RCSI School of Population Health UCC School of Public Health Institute of Public Health Irish College of GPs Irish Heart Foundation Francis Finucane Framing better sleep as an alternative to obesity medicine (not "weight loss drugs") is really unhelpful. Nobody is just casually "reaching for weight loss drugs" because they can't be arsed going to bed a bit earlier. People take these meds because behaviour change didn't work.

Professor Richard Scolyer AO (@profrscolyermia) 's Twitter Profile Photo

I was saddened to hear of the passing of the brilliant Perth fellow pathologist and 2005 Nobel Laureate in Medicine, J. Robin Warren AC. With his fine observational skills, Robin identified bacteria in the stomach (now called Helicobacter). This led to the discovery by him and

I was saddened to hear of the passing of the brilliant Perth fellow pathologist and 2005 Nobel Laureate in Medicine, J. Robin Warren AC. 

With his fine observational skills, Robin identified bacteria in the stomach (now called Helicobacter). This led to the discovery by him and
Alex Blakemore (@aifbw) 's Twitter Profile Photo

Confused about the olympic boxing scandal? Read this from one of our most eminent UK clinician scientists and a great communicator

Stuart Gillespie (@stuartgillesp16) 's Twitter Profile Photo

Yes...and a large part of prevention requires stronger regulation to address the harmful products and practices of most of your donors. Unless and until you acknowledge this you will simply be preaching to your own industry-funded choir...

Ali Aminian (@ali_aminian_md) 's Twitter Profile Photo

Published today in The Lancet Management of #obesity follows the same principles as management of other CHRONIC conditions. doi.org/10.1016/S0140-…

Published today in <a href="/TheLancet/">The Lancet</a> 

Management of #obesity follows the same principles as management of other CHRONIC conditions.

doi.org/10.1016/S0140-…
Christine Newman (@christine_new12) 's Twitter Profile Photo

Delighted to see the results of our priority setting partnership in adults living with type 1 diabetes published. Great Irish-UK work done to bring the most important research questions to the forefront! Sincere thanks to all those who participated! doi.org/10.1111/dme.15…

Michael Weintraub, MD (@mweintraubmd) 's Twitter Profile Photo

Tirzepatide was associated with 48% decreased kidney events compared to GLP1 RA, in a retrospective analysis of 140,308 patients with type 2 diabetes. Also with: ⬇️ 20% 🫀MACE ⬇️ 42% ☠️all cause mortality ⬇️ 0.34% a1c ⬇️2.9kg body weight We need full randomized clinical trials

Tirzepatide was associated with 48% decreased kidney events compared to GLP1 RA, in a retrospective analysis of 140,308 patients with type 2 diabetes.

Also with:
⬇️ 20% 🫀MACE
⬇️ 42% ☠️all cause mortality
⬇️ 0.34% a1c
⬇️2.9kg body weight

We need full randomized clinical trials